Ads
related to: biotech
Search results
Amid Biotech Pitfalls, This Stock Has Outperformed Nvidia in the Last 3 Months | Investing.com UK
Investing.com· 13 hours agoAlthough the Center for Drug Evaluation and Research (CDER) approved 86% of new molecular entities...
Adverum Biotechnologies Reports Q1 2024 Results: A Detailed Look at Financials and Pipeline Progress
GuruFocus.com via Yahoo Finance· 4 days agoNet Loss: Reported a net loss of $24.8 million for Q1 2024, an improvement from a net loss of $29.1 million in Q1 2023, but still above the estimated net loss of $26.89 million. Earnings Per ...
Earnings call: Humacyte anticipates strong market entry post-FDA review By Investing.com
Investing.com· 16 hours agoHumacyte, Inc. (HUMA), a biotechnology company specializing in regenerative medicine, has recently...
Biophytis Announces the Design of its Phase 2 OBA Clinical Study in Obesity
Benzinga· 3 hours agoPARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / May 14, 2024 / Biophytis SA ALBPS, ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the ...
Sana Biotechnology Inc [SANA] stock for 236,300 USD was sold by Yang Patrick Y – Knox Daily
Knox Daily· 5 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Sana Biotechnology Inc shares valued at $236,300 ...
EPA, FDA, and USDA Issue Joint Regulatory Plan for Biotechnology
USDA· 6 days agoIn response to President Biden’s Executive Order 14081, “Advancing Biotechnology and...
Insider Selling: ROBINS CHAD M, Adaptive Biotechnologies Corp [ADPT] CEO and Chairman divested...
Knox Daily· 4 days agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Adaptive Biotechnologies Corp shares valued at $167,007 were sold by ROBINS CHAD M on Mar ...
Benjamin F. Edwards & Company Inc. Grows Position in CollPlant Biotechnologies Ltd. (NASDAQ:CLGN)
ETF DAILY NEWS· 4 days agoBenjamin F. Edwards & Company Inc. raised its position in CollPlant Biotechnologies Ltd. (NASDAQ:CLGN – Free Report) by 11.3% in the fourth quarter, according to its most recent Form 13F filing ...
Down -19.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)
Zacks via Yahoo Finance· 4 days agoAdverum Biotechnologies (ADVM) is technically in oversold territory now, so the heavy selling...
Axxcess Wealth Management LLC Takes $30,000 Position in NautilusBiotechnology, Inc. (NASDAQ:NAUT)
ETF DAILY NEWS· 3 days agoAxxcess Wealth Management LLC purchased a new stake in shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Free Report) during the 4th quarter, according to its most recent ...
